• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用纳米材料调控免疫微环境:肿瘤免疫治疗的新策略。

Modulation of the immune microenvironment using nanomaterials: a new strategy for tumor immunotherapy.

作者信息

Piao Haozhe, Jiang Yuxin, Jin Shengbo, Shi Jie, Yu Jun, Wang Wenping, Du Zhenguang, Yao Huini, Liu Qian, Li Ningxin, Fu Jiaqing, Shen Yue, Li Mingzhu

机构信息

Department of Neurosurgery, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning, China.

Department of Integrated Traditional Chinese and Western Medicine Medical Oncology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning, China.

出版信息

Front Immunol. 2025 Jul 2;16:1614640. doi: 10.3389/fimmu.2025.1614640. eCollection 2025.

DOI:10.3389/fimmu.2025.1614640
PMID:40672947
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12263616/
Abstract

The complexity of the tumor immune microenvironment (TIME), which is composed of mainly tumor cells, immune cells, and cytokines, is a major obstacle limiting the effectiveness of immunotherapy, and the interactions among these factors in the TIME determine the efficacy of antitumor immunity. Over the past few years, nanomaterials, owing to their unique physicochemical properties, multifunctionality, and good targeting ability, have gradually become important tools for modulating the immune microenvironment. By precisely delivering immunomodulatory factors, nanomaterials can effectively activate dendritic cells (DCs), enhance the function of effector T cells, and reverse the immunosuppressive state of tumor-associated macrophages (TAMs). In addition, nanomaterials can alleviate the local hypoxic and acidic tumor microenvironment, which in turn promotes immune cell function and enhances the antitumor immune effect. In light of the aforementioned associations, we summarize the existing studies, systematically describe the latest research progress on the use of nanomaterials in regulating the tumor immune microenvironment, and analyze the potential applications and challenges in tumor immunotherapy, with the goal of providing new therapeutic directions and strategies for tumor immunotherapy.

摘要

肿瘤免疫微环境(TIME)主要由肿瘤细胞、免疫细胞和细胞因子组成,其复杂性是限制免疫治疗有效性的主要障碍,且这些因素在TIME中的相互作用决定了抗肿瘤免疫的疗效。在过去几年中,纳米材料由于其独特的物理化学性质、多功能性和良好的靶向能力,已逐渐成为调节免疫微环境的重要工具。通过精确递送免疫调节因子,纳米材料可有效激活树突状细胞(DC),增强效应T细胞的功能,并逆转肿瘤相关巨噬细胞(TAM)的免疫抑制状态。此外,纳米材料可缓解肿瘤局部缺氧和酸性微环境,进而促进免疫细胞功能并增强抗肿瘤免疫效应。鉴于上述关联,我们总结现有研究,系统描述纳米材料在调节肿瘤免疫微环境方面的最新研究进展,并分析其在肿瘤免疫治疗中的潜在应用和挑战,旨在为肿瘤免疫治疗提供新的治疗方向和策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d048/12263616/cc1d4cc418d6/fimmu-16-1614640-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d048/12263616/3b04ebc87de1/fimmu-16-1614640-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d048/12263616/647631106b06/fimmu-16-1614640-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d048/12263616/8f06d360e720/fimmu-16-1614640-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d048/12263616/38bdaf96d09a/fimmu-16-1614640-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d048/12263616/dc6a488d881e/fimmu-16-1614640-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d048/12263616/e63da7f024a3/fimmu-16-1614640-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d048/12263616/085245b4326f/fimmu-16-1614640-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d048/12263616/add7cf8d7e4b/fimmu-16-1614640-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d048/12263616/cacf62631d82/fimmu-16-1614640-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d048/12263616/cc1d4cc418d6/fimmu-16-1614640-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d048/12263616/3b04ebc87de1/fimmu-16-1614640-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d048/12263616/647631106b06/fimmu-16-1614640-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d048/12263616/8f06d360e720/fimmu-16-1614640-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d048/12263616/38bdaf96d09a/fimmu-16-1614640-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d048/12263616/dc6a488d881e/fimmu-16-1614640-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d048/12263616/e63da7f024a3/fimmu-16-1614640-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d048/12263616/085245b4326f/fimmu-16-1614640-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d048/12263616/add7cf8d7e4b/fimmu-16-1614640-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d048/12263616/cacf62631d82/fimmu-16-1614640-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d048/12263616/cc1d4cc418d6/fimmu-16-1614640-g010.jpg

相似文献

1
Modulation of the immune microenvironment using nanomaterials: a new strategy for tumor immunotherapy.利用纳米材料调控免疫微环境:肿瘤免疫治疗的新策略。
Front Immunol. 2025 Jul 2;16:1614640. doi: 10.3389/fimmu.2025.1614640. eCollection 2025.
2
Intratumoral injection of R848 and poly(I:C) synergistically promoted antitumor immune responses by reprogramming macrophage polarization and activating DCs in lung cancer.瘤内注射R848和聚肌胞苷酸通过重新编程巨噬细胞极化和激活肺癌中的树突状细胞,协同促进抗肿瘤免疫反应。
Clin Exp Immunol. 2025 Jan 21;219(1). doi: 10.1093/cei/uxae110.
3
Engineered GM-CSF polarizes protumorigenic tumor-associated macrophages to an antitumorigenic phenotype and potently synergizes with IL-12 immunotherapy.工程化的粒细胞-巨噬细胞集落刺激因子(GM-CSF)将促肿瘤的肿瘤相关巨噬细胞极化为抗肿瘤表型,并与白细胞介素-12免疫疗法产生强大的协同作用。
J Immunother Cancer. 2024 Dec 22;12(12):e009541. doi: 10.1136/jitc-2024-009541.
4
Biomimetic Nanomaterials Based on Peptide In Situ Self-Assembly for Immunotherapy Applications.基于肽原位自组装的仿生纳米材料在免疫治疗中的应用
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2025 Jan-Feb;17(1):e70005. doi: 10.1002/wnan.70005.
5
Oncolytic reovirus enhances the effect of CEA immunotherapy when combined with PD1-PDL1 inhibitor in a colorectal cancer model.在结直肠癌模型中,溶瘤呼肠孤病毒与PD1-PDL1抑制剂联合使用时可增强CEA免疫疗法的效果。
Immunotherapy. 2025 Apr;17(6):425-435. doi: 10.1080/1750743X.2025.2501926. Epub 2025 May 12.
6
Targeting HK3 in tumor-associated macrophages enhances antitumor immunity through augmenting antigen cross-presentation in cervical cancer.靶向肿瘤相关巨噬细胞中的HK3可通过增强宫颈癌中的抗原交叉呈递来增强抗肿瘤免疫力。
J Immunother Cancer. 2025 Jul 15;13(7):e011948. doi: 10.1136/jitc-2025-011948.
7
Ganoderic acid A regulates CSF1R to reprogram tumor-associated macrophages for immune therapy of hepatocellular carcinoma.灵芝酸A通过调节集落刺激因子1受体对肿瘤相关巨噬细胞进行重编程,用于肝细胞癌的免疫治疗。
Int Immunopharmacol. 2025 Aug 28;161:114989. doi: 10.1016/j.intimp.2025.114989. Epub 2025 Jun 7.
8
Mechanisms of tumor-associated macrophages promoting tumor immune escape.肿瘤相关巨噬细胞促进肿瘤免疫逃逸的机制。
Carcinogenesis. 2025 Apr 3;46(2). doi: 10.1093/carcin/bgaf023.
9
Inhibition of NFE2L1 Enables the Tumor-Associated Macrophage Polarization and Enhances Anti-PD1 Immunotherapy in Glioma.抑制NFE2L1可促进肿瘤相关巨噬细胞极化并增强胶质瘤的抗PD1免疫治疗。
CNS Neurosci Ther. 2025 Jul;31(7):e70488. doi: 10.1111/cns.70488.
10
Axl inhibitor-mediated reprogramming of the myeloid compartment of the tumor microenvironment is influenced by prior targeted therapy treatment.Axl抑制剂介导的肿瘤微环境髓样区室重编程受先前靶向治疗的影响。
Front Immunol. 2025 Jun 5;16:1601420. doi: 10.3389/fimmu.2025.1601420. eCollection 2025.

本文引用的文献

1
Advances in targeted therapy for tumor with nanocarriers: A review.纳米载体用于肿瘤靶向治疗的研究进展:综述
Mater Today Bio. 2025 Feb 15;31:101583. doi: 10.1016/j.mtbio.2025.101583. eCollection 2025 Apr.
2
Enhanced delivery of doxorubicin via transferrin-coated arylated gold nanostars for cancer therapy.通过转铁蛋白包被的芳基化金纳米星增强阿霉素递送用于癌症治疗。
Int J Pharm. 2025 Mar 30;673:125418. doi: 10.1016/j.ijpharm.2025.125418. Epub 2025 Feb 27.
3
The role of tumor-derived exosomal LncRNA in tumor metastasis.肿瘤来源的外泌体长链非编码RNA在肿瘤转移中的作用。
Cancer Gene Ther. 2025 Mar;32(3):273-285. doi: 10.1038/s41417-024-00852-x. Epub 2025 Feb 26.
4
Synergistic Nanoformulation: Streamlined One-Pot Synthesis Enhances Paclitaxel Functionalization Gold Nanoparticles for Potent Anticancer Activity.协同纳米制剂:简化的一锅法合成增强紫杉醇功能化金纳米颗粒的强效抗癌活性。
Cell Biochem Biophys. 2025 Feb 27. doi: 10.1007/s12013-025-01701-w.
5
Hydrophobic interactions enhance doxorubicin delivery from hyaluronic acid nanogels.疏水相互作用增强了透明质酸纳米凝胶对阿霉素的递送。
Eur J Pharm Biopharm. 2025 May;210:114676. doi: 10.1016/j.ejpb.2025.114676. Epub 2025 Feb 24.
6
Navigating the Clinical Landscape of Liposomal Therapeutics in Cancer Treatment.探索脂质体疗法在癌症治疗中的临床应用前景
Pharmaceutics. 2025 Feb 18;17(2):276. doi: 10.3390/pharmaceutics17020276.
7
Cancer-associated fibroblast-derived extracellular vesicles: regulators and therapeutic targets in the tumor microenvironment.癌症相关成纤维细胞衍生的细胞外囊泡:肿瘤微环境中的调节因子和治疗靶点
Cancer Drug Resist. 2025 Jan 7;8:2. doi: 10.20517/cdr.2024.152. eCollection 2025.
8
Double-targeted liposomes coated with matrix metallopeptidase-2-responsive polypeptide nanogel for chemotherapy and enhanced immunotherapy against cervical cancer.涂覆有基质金属肽酶-2响应性多肽纳米凝胶的双靶向脂质体用于宫颈癌的化疗和增强免疫治疗。
Mater Today Bio. 2024 Dec 17;30:101412. doi: 10.1016/j.mtbio.2024.101412. eCollection 2025 Feb.
9
Targeted CRISPR/Cas9 Lipid Nanoparticles Elicits Therapeutic Genome Editing in Head and Neck Cancer.靶向CRISPR/Cas9脂质纳米颗粒在头颈癌中引发治疗性基因组编辑。
Adv Sci (Weinh). 2025 Feb;12(7):e2411032. doi: 10.1002/advs.202411032. Epub 2024 Dec 30.
10
Nanoparticles and bone microenvironment: a comprehensive review for malignant bone tumor diagnosis and treatment.纳米颗粒与骨微环境:恶性骨肿瘤诊治的全面综述
Mol Cancer. 2024 Nov 1;23(1):246. doi: 10.1186/s12943-024-02161-1.